BRIEF-Adamis Pharma provides update on license pact with Allergan

* Decision follows Adamis' receipt from FDA of a complete response letter in june
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.